ChemoTrac Download

Date

Description

File

Apr 2012

This update contains the following revised forms:

	Bortezomib for Treatment of Multiple Myeloma
	Bortezomib fro Previously Untreated Multiple Myeloma

Please follow the steps to apply the update:

Download update2311 from the web site
Start ChemoTrac
Click Tools > Update Dictionary
Select the downloaded file
Click Open to apply the update

update2311 (350 KB)

Mar 2012

This patch contains the fix for the following eligibility forms:

	Vinorelbine for Non-Small Cell Lung Cancer
	Paclitaxel for Non-Small Cell Lung Cancer
	Gemcitabine for Non-Small Cell Lung Cancer
	Docetaxel for Non-Small Cell Lung Cancer

update231_patch (350 KB)

Feb 2012

This update contains the following new or updated eligibility forms:

	Cetuximab with Irinotecan for the 3rd Treatment of Metastatic Colorectal Cancer
	Irinotecan with Cetuximab for the 3rd Treatment of Metastatic Colorectal Cancer
	Vinorelbine for Non-Small Cell Lung Cancer
	Paclitaxel for Non-Small Cell Lung Cancer
	Gemcitabine for Non-Small Cell Lung Cancer
	Docetaxel for Non-Small Cell Lung Cancer
	Docetaxel for Non-Small Cell Lung Cancer (Following Platinum Doublet)
	Pemetrexed for Non-Small Cell Lung Cancer following Platinum Doublet Therapy
	Bevacizumab for 1st line Treatment of Metastatic Colorectal Cancer
	Oxaliplatin for Metastatic Colorectal Cancer
	Rituximab Retreatment for Indolent Lymphoma
	Pemetrexed for the Maintenance Treatment of Nonsquamous Non-Small Cell Lung Cancer
	Trastuzumab for the Second Line Treatment of Metastatic Breast Cancer
	Oxaliplatin (with Irinotecan) for Metastatic Pancreatic Adenocarcinoma
	Irinotecan (with Oxaliplatin) for Metastatic Pancreatic Adenocarcinoma
	Trastuzumab for Gastric Cancer

To install the new the update, unzip the downloaded update231.zip to c:\temp
Start ChemoTrac
Select on the main menu Tools|Update to Dictionary
Select update231.mdb from c:\temp and press Open

Note: DKK highly recommends you to backup ChemoTrac.mdb prior update.

update231.zip (3881 KB)

Dec 2011

This is a fix on the problem to submit the following form to CCO:

	Adjuvant trastuzumab with Chemotherapy for Her2/neu-overexpressing breast cancer tumours less than or equal to 1 cm in diameter (eligibility form for the Evidence Building Program)
	Azacitidine for myelodysplastic syndrome or acute myeloid leukemia

Please download the ChemoTrac.exe and replace the one on the system. It usually located at c:\program files\ChemoTrac directory

Note: DKK highly recommend you to backup the ChemoTrac.exe on your system prior the installation.

ChemoTrac.exe (1 MB)

Nov 2011

This update contains the following eligibility and supplemental forms:

	Adjuvant to metastatic trastuzumab for HER2/neu-overexpressing breast cancer (supplemental form)
	Adjuvant trastuzumab (and docetaxel) for Her2/neu-overexpressing breast cancer tumours less than or equal to 1 cm in diameter (eligibility form for the Evidence Building Program)
	Azacitidine for myelodysplastic syndrome or acute myeloid leukemia (revised eligibility form)
	Azacitidine for myelodysplastic syndrome or acute myeloid leukemia (supplemental form)

To install the new ChemoTrac application, unzip the downloaded ChemoTrac230p.zip to c:\temp. Please refer to readme.doc for the detail installation instruction.

Note: DKK highly recommend you to contact IT support to assist the installation process. Please make sure that you backup the ChemoTrac.exe and ChemoTrac.mdb prior the installation.

ChemoTrac230.zip (6.5 MB)

April 2010

This update contains the following changed eligibility forms:

	Bortezomib for Treatment of Multiple Myeloma
	Bortezomib for Previously Untreated of Multiple Myeloma

Update212.zip (1781 KB)

Sep 2010

This is a new ChemoTrac application version 2.10. The new version of ChemoTrac support the following new eligibility forms.

	Azacitidine for Myelodysplastic Syndrome or Acute Myeloid Leukemia
	Temsirolimus for Metastatic Renal Cell Carcinoma

This update will only work with ChemoTrac version 2.02 and up.

To install the new ChemoTrac application, unzip the downloaded Update210_Pass.zip to c:\temp. Please refer to readme.doc for the detail installation instruction.

Note: DKK highly recommend you to contact IT support to assist the installation process. Please make sure that you backup the ChemoTrac.exe and ChemoTrac.mdb prior the installation.

Update210_Pass.zip (4.4 MB)

Jun 2010

This is a replacement of Update203 due to runtime error on the following eligibility form:

	Docetaxel for NSCLC (2nd line)
	Raltitrexed for Clorectal Cancer
	Irinotecan for Colorectal Cancer (1st line)
	Irinotecan for Colorectal Cancer (2nd line)

Update2031_Pass.zip (1036 KB)

Jun 2010

********** Recall the Update *******

This update contains the following new or changed eligibility forms:

	New eligibility form "Rituximab for Previously Untreadted Chronic Lymphocytic Leukemia"
	Remove "Intent" from eligibility forms

This update will only work with ChemoTrac version 2.00 and up.

To install the new ChemoTrac application, unzip the downloaded Update203_Pass.zip to c:\temp. Please refer to readme.doc for the detail installation instruction.

Note: DKK highly recommend you to contract IT support to assist the installation process. Please make sure that you backup the ChemoTrac.exe and ChemoTrac.mdb prior the installation.

Update203_Pass.zip

May 2010

Patch update for 2.00

Update201

May 2010

This is a new ChemoTrac application version 2.00. The new version of ChemoTrac added Height, Weight, BSA and Intent as mandatory fields for all Eligibility forms.

To install the new ChemoTrac application, unzip the downloaded ChemoTrac2_Pass.zip to c:\temp. Please refer to readme.doc for the detail installation instruction.

Note: DKK highly recommend you to contract IT support to assist the installation process. Please make sure that you backup the ChemoTrac.exe and ChemoTrac.mdb prior the installation.

ChemoTrac2_Pass.zip (1036 KB)

Nov. 2009

This update contains the following new or changed eligibility forms:

New eligibility form "Cetuximab (with Irinotecan) for the 3rd line Treatment of Metastatic Colorectal Cancel"

New eligibility form "Irinotecan (with Cetuximab) for the 3rd line Treatment of Metastatic Colorectal Cancel"

	Patients will need to enrolled for both drugs separately. However, eligibility questions will only need to be filled out with the "Cetuximab (with Irinotecan)" form.
	A reminder for filling out "Cetuximab (with Irinotecan)" form is exist on "Irinotecan (with Cetuximab) form.
	The user must click on the "Save" button under "Irinotecan (with Cetuximab)" Eligibility Criteria tab to acknowledge the reminder.

update135Pass.zip (288 KB)

Jun. 2009

The update file is password protected. Please contact DKK for the password.

This update contains the following new or changed eligibility forms:

	New eligibility form "Cetuximab & Radiation for Locally Advanced Squamous Cell Carcinoma of the Head & Neck"
	New eligibility form "Bortezomib for previously untreated multiple myeloma"
	New eligibility form "Docetaxel for Early Operable Breast Cancer"
	Updated "Rituximab for Aggressive Histology Lymphoma" eligibility form
	Updated "Rituximab in Combination with Chemotherapy for Indolent B-cell Lymphoma" eligibility form

update134p.zip (288 KB)

May. 2009

This update contains change for the following eligibility forms:

	Pemetrexed for Second-line Treatment of Non-Samll Cell Lung Cancer
	Oxaliplatin for Metastatic Colorectal Cancer
	Adjuvant Trastuzumab for HER2/neu-Overexpressing Primary Breast Cancer
	Rituximab for Aggressive Histology Lymphoma
	Rituximab Maintenance Therapy for Lymphoma
	Rituximab in Combination with Chemotherapy for Indolent B-cell Lymphoma
	Rituximab Single-Agent for Indolent Lymphoma
	Gemcitabine for Pancreatic Cancer
	Fludarabine for Indolent Lymphoma

update1331p.zip (138 KB)

Jan. 2009

This is a new ChemoTrac application version 1.32. The new version of ChemoTrac fixed the following problems:

	Date format compatibility
	Enlarge drug/disease selection screen

To install the new ChemoTrac application, unzip the downloaded ChemoTrac131.zip to c:\temp. And then, replace the existing c:\Program Files\ChemoTrac\ChemoTrac.exe with the one that you unzipped in temp directory. Please make sure you make a backup of the old ChemoTrac.exe before replace it.

ChemoTrac132.zip (138 KB)

Dec. 2008

This update contains the following:

	New eligibility form for 'Panitumumab for Treatment of Metastatic Colorectal Cancer'
	Typo correction on eligibility form for 'Docetaxel (AC-Taxotere regimen) for Neoadjuvant Treatment of Non-Metastatic Breast Cancer'
	Typo correction on eligibility form for 'Docetaxel (AC-Taxotere regimen) for Adjuvant Treatment of Non-Metastatic Breast Cancer'

update132.zip (592 KB)

Aug. 2008

This update contains the following:

	New eligibility form for 'Pemetrexed for Second-line Treatment of Non-Small Cell Lung Cancer'
	New eligibility form for 'Neoadjuvant Treatment of Non-Metastatic Breast Cancer'
	New eligibility form for 'Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer - Additional 4 cycles'
	New eligibility form for 'Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer'
	New eligibility form for 'Docetaxel as part of the AC-Taxotere regimen for the Adjuvant Treatment of Breast Cancer'

update131.zip (592 KB)

Mar. 2008

This update contains the following:

	New eligibility form for Nab-paclitaxel for Metastatic Breast Cancer
	Revised eligibility form for Rituximab for Aggressive Histology Lymphoma
	Revised eligibility form for Rituximab in Combination with Chomotherapy for Lymphoma
	Revised eligibility form for Rituximab Maintenance Therapy for Lymphoma

update130.zip (238 KB)

Aug. 2007

This update contains the following revised and new eligibility forms:

De-listed Eligibility Forms:

	New eligibility form of Oxaliplatin for Metastatic Colorectal Cancer
	Oxaliplatin for Adjuvant Treatment of Stage III and High-Risk Stage II Colon and Rectal Cancer
	Reviesed eligibility form of Pamidronate for Plasma Cell Myeloma

update129.zip (236 KB)

Mar. 2007

This update contains the following update on eligibility forms:

De-listed Eligibility Forms:

	Paclitaxel for the Adjuvant Treatment of Completely Resected Stage Ib or II Non-Small Cell Lung Cancer
	Paclitaxel for Advanced Ovarian Carcinoma (2nd or 3rd line therapy)
	Liposomal Doxorubicin for Advanced Ovarian Cancer (2nd and 3rd-line)
	Topotecan for Advanced Ovarian cancer (2nd and 3rd-line)

New Eligibility Forms:

	Rituximab Maintenance Therapy for Lymphoma
	Paclitaxel for the Adjuvant Treatment of Completely Resected Stage II or IIIa Non-Small Cell Lung Cancer
	Paclitaxel for Platinum-Sensitive Ovarian Cancer (Single-Agent Treatment)
	Liposomal Doxorubicin for Platinum-Sensitive Ovarian Cancer (Single-Agent Treatment)
	Topotecan for Platinum-Sensitive Ovarian Cancer (Single-Agent Treatment)
	Liposomal Doxorubicin for Platinum-Resistant Ovarian Cancer
	Topotecan for Platinum-Resistant Ovarian Cancer

Revised Eligibility Forms:

Adjuvant Trastuzumab for HER2/neu-OverExpressing Primary Breast Cancer - Minor wording change

update128.zip (240 KB)

Aug. 2006

This update contains the following revised or new eligibility forms:

New eligibility form of Bortezomib for the Treatment of Multiple Myeloma

New eligibility form of Raltitrexed for the treatment of Advanced Malignant Pleural Mesothelioma (MPM)

New eligibility form of Epirubicin and Docetaxel as part of the FECT Regimen for the Adjuvant Treatment of Breat Cancer

	In order to reimburse for both durgs, two eligibility forms have to be filled
	Fill in the eligibility form of Epirubicin for the Adjuvant Treatment of Breat Cancer and Select the FECT regimen option
	Fill in the eligibility form of Docetaxel for the Adjuvant Treatment of Breat Cancer and make sure that you click on 'Save' button under eligibility tab to acknowledge that you fill in the Epirubicin eligibility form

update127.zip (309 KB)

Mar. 2006

This update contains the following revised or new eligibility forms:

New eligibility form of Paclitaxel for the Adjuvant Treatment of Completely Resected Stage Ib or II Non-Small Cell

Revised eligibility form for 1st-line therapy of

	Paclitaxel for Advanced Ovarian Carcinoma
	Paclitaxel for Fallopian Tube Cancer
	Primary Peritoneal Cancer

New eligibility form for recurrent treatment of

	Paclitaxel for Advanced Ovarian Carcinoma
	Paclitaxel for Fallopian Tube Cancer
	Primary Peritoneal Cancer

New eligibility form of Paclitaxel for Uterine Papillary Serous Carcinoma (UPSC) (1st-line therapy and recurrent treatment)

update126.zip (166 KB)

Aug. 2005

This update contains the following revised or new eligibility forms:

Revised eligibility forms of Docetaxel, Paclitaxel, and Vinorelbine for the treatment of Metastatic Breast Cancer.

Revised eligibility forms for Trastuzumab for Metastatic Breast Cancer

	Combination treatment with trastuzumab and paclitaxel or docetaxel
	Combination treatment with trastuzumab and vinorelbine

New eligibility form of Doctaxel for Hormone-Refractory Prostate Cancer

New eligibility form of Adjuvant Trastuzumab for Her2/neu-OverExpressing Primary Breast Cancer

New eligibility form of Vinorelbine for the Adjuvant Treatment of Completely Resected Stage IB or II Non-Small Cell Lung Cancer

update125.zip (171 KB)

Feb. 2005

This is a new ChemoTrac application version 1.31. The new version of ChemoTrac fixed the following problems:

	Print Partial Miscellaneous Form
	Runtime overflow error
	Eligibility Form printout not align
	Handle null string exception

ChemoTrac131.zip (138 KB)

Jan. 2005

Fixed Trastuzumab for Metastatic Breast Cancer eligibility forms that require both 'FISH' and 'IHC3+' on question a 'Her2/neu Status' to be checked in order to make the form eligible.

update124_patch.zip (160 KB)

Aug. 2004

This update contains the following revised or new eligibility forms:

	Rituximab for Lymphoma
	Trastuzumab for Metastatic Breast Cancer
	Pamidronate for Plasma Cell Myeloma
	Docetaxel for Neoadjuvant Treatment of Patients with Non-Metastatic Breast Cancer
	Rituximab in Combination with Chemotherapy for Lymphoma
	Rituximab for Aggressive Histology Lymphoma
	Palliative Bone Seeking Radiopharmaceuticals (PBSR)

update124.zip (206 KB)

Jun. 2004

This update contains the revised eligibility forms of Docetaxel, Paclitaxel, and Vinorelbine for the treatment of Metastatic Breast Cancer.

update123.zip (154 KB)

Feb. 2004

This update will accommodate the new eligibility of Zoledronic Acid for Hormone-Refractory Prostate Cancer as outlined by CCO in their recent memo.

update122.zip (330 KB)

Aug. 2003

This update will accommodate the revision of eligibility of Docetaxel for the first line treatment of Metastatic Breast Cancer as outlined by CCO in their recent memo.

update121.zip
(329 KB)

Apr. 2003

This update will accommodate the change of the Eligibility Form for Docetaxel, Gemcitabine, Paclitaxel, and Vinorelbine for the first line treatment of NSCL cancer, as well as, Fludarabine for the treatment of Lymphoma and Waldenstrom's macrogloblinemia. (Please make sure to insert Fludarabine's unit price in the Dictionary).

You will also notice that the "Pre-approved" feature is NOT working yet until we get the approval from CCO.

Please be advised that the process of this update will take approximately two to three minutes.

update120.zip (328 KB)

Oct. 2002

This update (Update109.zip) contains two files: (1) chemotrac.exe which gives you the application version 1.101 and (2) Update109.mdb which provides you with the changes as outlined below:

	Photofrin has been added under Non-Small Cell Lung Cancer
	Changes on the Eligibility Form of IV Clondronate for Metastatic Breast Cancer
	Changes on the Eligibility Form of Pamidronate for Metastatic Breast Cancer
	Changes on the Eligibility Form of Vinorelbine and Gemcitabine for Non-Small Cell Lung Cancer

Please BACKUP your database (chemotrac.mdb) first.

After you have unzipped the attached file, you must replace your current chemoTrac.exe FIRST, before you perform the update of the database.

After you have replaced the chemotrac.exe file and performed the update, the splash screen from Help/About ChemoTrac should show version 1.101 and Database version 1.09.

update109.zip (284 KB)

Jul. 2002

Update108.mdb provides the following update to your database:

	Make some changes in the existing Epirubicin Eligibility Form used for Adjuvant Treatment of Breast Cancer. (You have received the change quite a while ago on the paper Eligibility Form)
	Correct the drug name of Liposomal Doxorubicin (previously just Doxorubicin)

Please save the Update108.mdb file into your appropriate folder.

To perform the update, invoke the ChemoTrac program, select Tools/Update Dictionary and select Update108.mdb (Note that the update might take more than one minute to perform. Please be patient)

Update108.zip (198 KB)

Mar. 2002

Finally, we have completed the testing of the web base data upload to CCO program. This new program will allow users to send data directly to CCO via the internet. The data will be encrypted and sent to a secured CCO server. Users will have a choice to sent data via the web or still export their data to a diskette.

Please find in the attached a zipped file that contains two files: Chemotrac.exe and Update107.mdb.

Regardless of the choice of your method of sending the data, you will need to replace the existing program file (chemotrac.exe) and perform the update with the Update107.mdb file in order to keep current with the program. The new program will have "version 1.1" displayed on the splash screen when you invoke the Chemotrac program.

Full instructions for this update is documented here.

Version11.zip (282 KB)

Jan. 2002

This update accommodates the changes included in the Memo by Marilyn Nefsky dated September 25, 2001.

Please also note that "Doxorubicin" that appears in the drug selection table for the second and the third line Ovarian Cancer is the same as "Liposomal Doxorubicin". A correction will be made in the next update.

Update106.zip (90 KB)

Mar. 2001

This update contains ChemoTrac.exe version 1.03b. We have added the database update version number to be viewed in the Help/About Chemotrac menu. Please replace your existing ChemoTrac.exe with this one.

The Update104.mdb is your regular database update file which will allow users to submit the new drugs:

	Rituximab for DLBCL and PTLD
	Epirubicin and Paclitaxel for Adjuvant Treatment of Breast Cancer
	Gemcitabine for Bladder or Urothelium

Please perform the database update by clicking: Tools/Update Dictionary and selecting the Update104.mdb file.

With Update104.mdb, you will also notice some minor changes on the Eligibility Form of Irinotecan (1st line) for Colorectal Cancer; and on the Eligibility form of Rituximab for DLBCL.

Update0301.zip (284 KB)

Jan. 2001

This update fixes a bug that prevents some of the data from being recognized by CCO. This update contains a new ChemoTrac.exe file that should replace the existing one.

Update0101.zip (149 KB)

Nov. 2000

This update fixes a bug which causes a problem when printing Eligibility Forms. The update has two components: ChemoTrac version 1.03a program (ChemoTrac.exe) and Update1100.mdb.

Please follow the instructions as listed below:

	Replace the existing Chemotrac.exe file by the new one being sent. (After replacement, you should find it reads 1.03a when you open up the Help in the Main menu)
	Invoke the ChemoTrac program. WHILE the splash screen is being displayed, press down the following keys together: <Shift>; <Ctrl>; and <Delete>. You should see a dialog box confirming that the database has been deleted. (Your data will NOT be deleted. Only the template of the Eligibility form is deleted). Press the OK button.
	Do the update with Update1100.mdb (This will restore the proper template of the Eligibility form).

All users should replace the program and the database template whether there's a problem printing out the Eligibility forms or not.

Update1100.zip (253 KB)

Oct. 2000

This update has two components: ChemoTrac version 1.03 program (ChemoTrac.exe) and Update1000.mdb.

Version 1.03 MUST be installed before performing Update1000.mdb. Install version 1.03 simply by replacing the existing ChemoTrac.exe (version 1.02) by this ChemoTrac.exe (version 1.03).

Update1000.mdb accommodates the following revised Eligibility Forms:

	Vinorelbine; Paclitaxel and Docetaxel for Metastatic Breast Cancer
	Vinorelbine for Non-Small Cell Cancer
	Pamidronate for Plasma Cell Myeloma
	Pamidronate for Metastatic Breast Cancer
	Gemcitabine for Pancreatic Cancer
	Gemcitabine for Non-Small Cell Lung Cancer

Update1000.zip (255 KB)

Aug. 2000

This update accommodates Liposomal Anthracycline for HIV-positive Kaposi's Sarcoma.

Update0800.zip (105 KB)

May 2000

This file is needed to accommodate Rituximab.

To update, simply invoke the ChemoTrac program. Select Tools from the main menu. Select Update to Dictionary. Go to the folder where you have the Update0500.mdb and press the "Open" button, or simply double click the Update0500.mdb file. (You'll need to unzip Update0500.zip first!)

Update0500.zip (105 KB)

Feb. 2000

This update (1.02) will allow users to enter Irinotecan as the first line and the second line treatment of colorectal cancer. It also provides the entry for the use of Docetaxel for non-small cell lung cancer.

Directions to update ChemoTrac:

	Unzip the Update0200.zip file to get the new chemotrac.exe file and update0200.mdb file;
	Replace the existing chemotrac.exe (version 1.01) with the new chemotrac.exe (version 1.02);
	Invoke the ChemoTrac program. Select Tools on the main menu. Select Update to Dictionary. Go to the folder where you have the Update0200.mdb and press the "Open" button, or simply double click the Update0200.mdb file.

Update0200.zip (267 KB)

Nov. 1999

ChemoTrac version 1.01 includes the following changes:

	BSA fields on all applicable Eligibility Forms are mandatory (required by CCO). Failure to enter BSA will prompt ChemoTrac to display an error message prompting users to complete all mandatory fields.
	The "Weight" field on Trastuzumab Eligibility Form is mandatory.
	Text fields included in criteria listed on the Eligibility Criteria are mandatory and must be filled.
	Health Insurance Number field has a fixed length of 10 digits and only accepts numerals.
	All flags prompting letters from physician have been removed (CCO will not require letters from physician to continue treatment).

Users are reminded to read and follow the instructions for installing version 1.01 and Update1099.mdb as outlined in the Readme.txt file.

Update1099.zip (246 KB)

July 1999

For Topotecan, ChemoTrac requires users to check both boxes on criteria (a) and (b). It should be just either (a) or (b).

Update0799.zip (95 KB)